July 22, 2003 Comments Off on BIO leader hits proposal for drug price regulation Posted in: General Biotechnology BIO leader hits proposal for drug price regulation The Cambridge-based chairman of the nation’s largest biotech organization is strongly opposing any federal controls in drug pricing if a prescription drug component is added to Medicare. “It’s price controls or innovation; you can’t have both,” said Richard Pops, who recently was elected to head the board […]
Biotech industry in survival mode Restructuring, retrenching and reinventing themselves, Bay Area biotechnology firms are adapting to weather the economic downturn. … “We’ve noticed (biotech companies) will abandon one or two research products and in the process may have discovered something of more use, readjusting their core competency to find something marketable today, rather than […]
